Please select the eligibility criteria that correspond to the clinical trial below.
Title: Implementation of HIT-Enhanced Tobacco Treatment for Hospitalized Smokers
Brief Summary: This study will implement and test the effectiveness and cost-effectiveness of a tobacco cessation intervention (Academic Detailing + Integrated Tobacco Order Set - AD + ITOS) for adults admitted to the hospital. The intervention will begin during the hospital stay and continue after discharge. The intervention will use resources easily available to most acute care hospitals: computerized physician order entry, physician and nurse education, staff meetings for physicians, nurses and allied health professionals, online learning capabilities, faxing to primary care providers (PCPs), and the telephone counseling and support available from a state smokers' quitline (QL).

The investigators hypothesize that the subjects in the intervention arm (AD + ITOS) will be more likely to achieve tobacco abstinence at 12 months post hospital stay than subjects in the control arm (Academic Detailing - AD). Tobacco abstinence will be assessed by self report and biochemical verification (exhaled carbon monoxide reading).


Options:
A: Inclusion Criteria: All injured patients \> 15 years old who are brought or present to the The Alfred Trauma Centre during the study period.

Exclusion Criteria: Stable Trauma patients (ie Pulse rate \<100/minute, MAP \>70mmHg, Hb \>70, temperature \>35 and \<37.5, Spo2 \>92%, GCS \>13) undergoing secondary transfer from another hospital, where trauma occurred \>6hrs prior to arrival.
B: Inclusion Criteria:

* 18 years or older
* admitted to any medical ward, telemetry or cardiac care unit
* identified as a smoker by the nurse or physician in the admitting EMR
* treated by a study physician
* able to give written informed consent

Exclusion Criteria:

* inability to read or understand English or Spanish
* lacks capacity to give informed consent
* currently receiving formal tobacco dependence treatment
* current suicide or homicide risk
* current psychotic disorder or life-threatening or unstable medical or psychiatric condition within past 6 months
* unable to provide 2 telephone contact numbers
* unwilling to follow up per study protocol, including release of information to assess treatment engagement at 30-days
* live outside of New Haven County
* leaving the hospital against medical advice
* history of clinically significant allergic reaction to nicotine replacement therapies, varenicline or bupropion
* use of an investigational drug within 30 days
* use of tobacco products other than cigarettes
* women of childbearing potential who are pregnant, nursing, or sexually active and not practicing effective contraception (oral injectable, or implantable contraceptives, intrauterine device, or barrier method with spermicide)
* do not have access to a phone with a CT area code (required to use the CT Tobacco Quitline)
C: Inclusion Criteria:

* Physicians are eligible for inclusion if they are general practitioners or family physicians in full-time (≥ 4 days/week), fee-for-service practice in Quebec
* Patients where the study physician has written or dispensed prescriptions for beta2-agonists, anti-leukotrienes, or inhaled corticosteroids, and has verified the diagnosis of asthma

Exclusion Criteria:

* Younger than 5 years old
* Diagnosis of COPD
D: Inclusion Criteria:

* Age ≥2 months and \<60 months of age
* Written informed consent from the child's parent or caregiver
* Axillary temperature ≥37.5°C and/or tympanic temperature ≥38.0°C
* History of fever for ≤7 days
* First consultation for the current illness
* Live in the catchment area of the health facility

Exclusion Criteria:

* Age 60 months or greater
* Age less than 2 months
* Weight less than 2.5kg
* Chief health problem is an injury, trauma or acute poisoning

Answer: B